Our results demonstrated that CCR2+Ly6Chi monocytic myeloid cells regulate tumor response to radiation by suppressing T cell function instead of impacting vascularization in tumors (Fig. 2e), thereby eliminating the MDSC population enhanced T cell function as well as the anti-tumor response to radiation. Here, CCR2 is linked to neoplasm.